(Health Korea News / Changyong Lee) ‘Pharmaceutical 24 Hours’ is a corner that shows brief news related to pharmaceutical and biotechnology at a glance that is easy to miss. It may seem like trivial news, but it could be valuable information to someone, so we summarize the facts and present them in an easy-to-understand manner.
◆ GC Pharma received a commendation from the Minister of Health and Welfare as an innovative pharmaceutical company.
GC Green Cross received the Minister of Health and Welfare Award for Innovative Pharmaceutical Company at the ‘2024 Health Industry Performance Exchange’ on the 28th.
In December of last year, GC Green Cross obtained product approval from the U.S. Food and Drug Administration (FDA) for its representative blood product product, immunoglobulin ‘ALYGLO’, and succeeded in entering the U.S. blood product market, the world’s largest, for the first time in Korea.
At this award, GC Pharma was recognized for its contributions to improving public health and developing the pharmaceutical industry through the advancement of blood product ‘Aliglo’ into the U.S., development of vaccines and blood products that are essential national medicines, and innovative new drugs for rare and intractable diseases. evaluated.
Lee Jae-woo, head of GC Pharma’s development division, was selected as an awardee for excellence in exports for his contribution to the development of ‘Aliglo’, the 8th domestically produced new drug approved by the U.S. FDA, and to the development of rare disease treatments and increased overseas exports, and was awarded by the Korea Health Industry Development Institute. received a commendation
◆ HIRA selected as an excellent public data quality management organization by the Ministry of the Interior and Safety
On the 28th, the Health Insurance Review and Assessment Service was selected as an excellent organization in the ‘2024 Public Data Quality Certification’ hosted by the Ministry of Public Administration and Security.
HIRA has been certified as an excellent institution for three consecutive years since 2022, when the Ministry of the Interior and Safety institutionalized the quality certification system to secure high-quality public data.
The selection committee for quality certification of excellent institutions comprehensively evaluated three areas: ▲public data value, ▲public data management, and ▲public data utilization to establish a quality management system for public institutions.
Among the 679 administrative and public institutions subject to public data quality management, 8 institutions (1.1%), including the Review and Assessment Service, have been certified as excellent institutions for three consecutive years.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
